货号:A542979 同义名:
Norethindrone;NSC 9564
Norethisterone是一种合成孕激素,模拟内源性卵巢激素的作用,常用于治疗子宫内膜异位症和由激素水平异常引起的子宫出血及继发性闭经。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
描述 | Progesterone Receptor (PGR) is a member or the steroid receptor superfamily. It mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. Progesterone Receptor is involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as transcriptional activator or repressor. Norethindrone, also termed Norethisterone (NET) is a synthetic 19-nortestosterone derivative. Norethindrone acts as a ligand that binds to progesterone receptor. According to published data, mean of relative binding affinity (RBA) values of norethisterone to the progesterone, androgen and estrogen receptor in cytosol of human breast MCF-7 cells and to the glucocorticoid receptor in that of leukemic IM-9 cells were 21.5%, 3.2%, not binding, and 0.8%, respectively. These data were all expressed as percentage of standard ligands of Org 2058, 5a-dihydrotestosterone (DHT), estradiol (E2) and dexamethasone (Dex), respectively[3]. Mean of relative agonistic activity (RAA) values of norethisterone to the progesterone, androgen, estrogen and glucocorticoid receptor in transactivation assays with CHO cells using Org 2058, 5a-dihydro-testosterone (DHT), estradiol (E2) and dexamethasone (Dex) as standards were also measured. The data (also expressed as percentage of standard ligands) were 12.4%, and 1.1% respectively for the progesterone and androgen receptor, while no transactivation was detected for the estrogen or glucocorticoid receptor[3]. According to cell proliferation data measured by an ATP-chemosensitivity test, norethisterone inhibited MCF-7 cells proliferation between 23% and 41% over the concentration range of 0.01 nM to 10 μM tested. In vivo, the mean active doses (MAD) of norethisterone in progestagenic (McPhail), androgenic (Hershberger), estrogenic (Allen–Doisy) tests, and in a progestagenic and estrogenic (ovulation inhibition test) were 0.063 mg/kg, 2.5 mg/kg, 4 mg/kg and 0.235 mg/kg respectively after subcutaneous administration and 0.25 mg/kg, 20 mg/kg, 8 mg/kg and 12 mg/kg respectively after oral administration[3]. |
Dose | Rat: 10 mg/kg, 50 mg/kg[3] (p.o.), 8 mg/kg[2] (p.o.); 4 mg/kg[2] (s.c.) |
Administration | p.o., s.c. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01129102 | Dysmenorrhea | Phase 3 | Completed | - | - |
NCT01466114 | Relapsing-remitting Multiple S... 展开 >>clerosis Secondary-progressive Multiple Sclerosis Primary-progressive Multiple Sclerosis 收起 << | Phase 2 | Recruiting | December 2018 | United States, California ... 展开 >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Mike Montag, M.S. 310-206-2176 MMontag@mednet.ucla.edu Sub-Investigator: Barbara Giesser, MD Sub-Investigator: Callene Momtazee, MD United States, Colorado The University of Colorado Denver Completed Aurora, Colorado, United States, 80045 United States, New Mexico The University of New Mexico Completed Albuquerque, New Mexico, United States, 87131 United States, Pennsylvania The University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Amber Roberts 215-662-4893 daj37@mail.med.upenn.edu Principal Investigator: Dina Jacobs, M.D. 收起 << |
NCT01129102 | - | Completed | - | - | |
计算器 | ||||
存储液制备 | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 3.35mL 0.67mL 0.34mL | 16.75mL 3.35mL 1.68mL | 33.51mL 6.70mL 3.35mL |
CAS号 | 68-22-4 |
分子式 | C20H26O2 |
分子量 | 298.419 |
别名 | Norethindrone;NSC 9564;Norethindrone, Norethisterone, 19-nor-17α-ethynyltestosterone, Utovlan;SC 4640 |
运输 | 蓝冰 |
存储条件 | In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 | DMSO: 25 mg/mL(83.77 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 2.5 mg/mL(8.38 mM),配合低频超声助溶 |
动物实验配方 | IP 2% DMSO+2% Tween80+40% PEG300+water 2 mg/mL clear PO 0.5% CMC-Na 30 mg/mL suspension |
Tags: Norethindrone | 68-22-4 | Norethisterone | Progesterone Receptor | Progesterone Receptor Agonist | Vitamin D Related/Nuclear Receptor | Anti-infection | Progesterone Receptor | Bacterial | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Norethisterone 纯度/质量文件 | Norethisterone 生物活性 | Norethisterone 动物研究 | Norethisterone 临床数据 | Norethisterone 参考文献 | Norethisterone 实验方案 | Norethisterone 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01129102 | Dysmenorrhea | Phase 3 | Completed | - | - |
NCT01466114 | Relapsing-remitting Multiple S... 展开 >>clerosis Secondary-progressive Multiple Sclerosis Primary-progressive Multiple Sclerosis 收起 << | Phase 2 | Recruiting | December 2018 | United States, California ... 展开 >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Mike Montag, M.S. 310-206-2176 MMontag@mednet.ucla.edu Sub-Investigator: Barbara Giesser, MD Sub-Investigator: Callene Momtazee, MD United States, Colorado The University of Colorado Denver Completed Aurora, Colorado, United States, 80045 United States, New Mexico The University of New Mexico Completed Albuquerque, New Mexico, United States, 87131 United States, Pennsylvania The University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Amber Roberts 215-662-4893 daj37@mail.med.upenn.edu Principal Investigator: Dina Jacobs, M.D. 收起 << |
NCT01129102 | - | Completed | - | - | |
NCT01590420 | Obstructive Sleep Apnea Syndro... 展开 >>me 收起 << | Phase 4 | Unknown | March 2014 | Brazil ... 展开 >> Associação Fundo de Incentivo à Pesquisa Recruiting Sao Paulo, Brazil, 04024-002 Contact: Camila F Rizzi, PhD +55 (11) 85555049 camila.rizzi@unifesp.br Principal Investigator: Camila F Rizzi, PhD 收起 << |
NCT01044498 | Rheumatoid Arthritis | Phase 3 | Completed | - | United States, Arkansas ... 展开 >> Little Rock, Arkansas, United States, 72212 United States, California Beverly Hills, California, United States, 90211 United States, Florida Ormond Beach, Florida, United States, 32174 Port Orange, Florida, United States, 32127 United States, Pennsylvania Duncansville, Pennsylvania, United States, 16635 United States, Texas San Antonio, Texas, United States, 78222 收起 << |
NCT00877097 | Osteoporosis | Not Applicable | Completed | - | - |
NCT00825617 | Turner Syndrome | Not Applicable | Completed | - | Denmark ... 展开 >> Medical department M and Investigational Laboratories Aarhus C, Jutland, Denmark, 8000 收起 << |
NCT03648996 | Diabetes Mellitus, Type 2 ... 展开 >> Hyperuricemia 收起 << | Phase 2 | Not yet recruiting | September 30, 2021 | - |
NCT01656434 | - | Terminated(Business reasons) | - | - | |
NCT02264743 | Venous Thrombosis ... 展开 >> Insulin Resistance 收起 << | Phase 4 | Unknown | November 2015 | United Kingdom ... 展开 >> Chelsea and Westminster NHS Foundation Trust Recruiting London, United Kingdom, SW10 9NH Contact: Nick Panay, MBBS, MRCOG 0203 331 8112 n.panay@imperial.ac.uk Sub-Investigator: Nick Panay, MBBS,MRCOG Royal Brompton and Harefield NHS Trust Recruiting London, United Kingdom, SW3 6NP Principal Investigator: John Stevenson, MBBS Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W12 0HS Contact: Nick Panay, MBBS, MRCOG 0203 331 8112 n.panay@imperial.ac.uk Sub-Investigator: Nick Panay, MBBS, MRCOG 收起 << |
NCT01656434 | Contraception | Phase 3 | Terminated(Business reasons) | - | - |
NCT01044498 | - | Completed | - | - | |
NCT00604747 | Stroke | Not Applicable | Completed | - | Brazil ... 展开 >> Camila Torriani São Paulo, SP, Brazil, 02415000 收起 << |
NCT01713010 | - | Unknown | December 2012 | Brazil ... 展开 >> Federal University of Uberlandia Recruiting Uberlandia, Minas Gerais, Brazil, 38408-100 Contact: Camila Marques Dias 55 34 33388655 camilamd15@yahoo.com.br 收起 << | |
NCT00004763 | Hyperandrogenism | Phase 2 | Completed | - | - |
NCT00919919 | Endometrial Hyperplasia ... 展开 >> Endometrial Cancer 收起 << | Phase 2 | Unknown | November 2010 | Israel ... 展开 >> Rabin Medical Center Beilinson Hospital Not yet recruiting Petach Tikva, Israel Contact: Aviva kaplan 972-50-5511591 Principal Investigator: Boris kaplan, prof Sub-Investigator: Michael Hirsh, Dr' Sub-Investigator: Ravit Nahum, Dr' Sub-Investigator: Dove Lazarovitz, Dr' Sub-Investigator: Avi Ninio, Dr' Sub-Investigator: Yosi Maai, Dr' Sub-Investigator: Dan Kelman, Dr' Sub-Investigator: Raia Nir, Dr' Sub-Investigator: Ruth Bloch, Dr' Sub-Investigator: Yehuda Yeger, Dr' Sub-Investigator: Reuven Amster, Dr' Sub-Investigator: Tzvi Zehavi, Dr' Sub-Investigator: Gay Gutman, Dr' Sub-Investigator: Yosi Menkas, Dr' 收起 << |
NCT02928809 | Temporomandibular Joint Disord... 展开 >>ers 收起 << | Not Applicable | Unknown | December 2016 | Brazil ... 展开 >> Universidade Nove de Julho Recruiting Sao Paulo, SP, Brazil, 01504-001 Contact: Camila HL Godoy, MS 55 11 32623166 cami_godoy@outlook.com 收起 << |
NCT03749070 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Not yet recruiting | June 30, 2021 | - |
NCT00003771 | Breast Cancer ... 展开 >> Menopausal Symptoms 收起 << | Phase 3 | Completed | - | Finland ... 展开 >> Helsinki University Central Hospital Helsinki, Finland, FIN-00029 Norway Norwegian Radium Hospital Oslo, Norway, N-0310 Poland Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 Sweden Karolinska Hospital Stockholm, Sweden, S-171 76 Uppsala University Hospital Uppsala, Sweden, S-75185 Switzerland Breast Center Zurich, Switzerland, CH-8008 收起 << |
NCT01494974 | Pediatric Glaucoma | Phase 4 | Unknown | - | Brazil ... 展开 >> Federal University of São Paulo - Ophthalmology Department Recruiting São Paulo, Brazil, 04023-062 Contact: Camila F Netto, MD +55-11-99177717 milanetto@gmail.com Principal Investigator: Camila F Netto, MD 收起 << |
NCT03451110 | Healthy Subjects | Phase 1 | Completed | - | United States, Texas ... 展开 >> Worldwide Clinical Trials San Antonio, Texas, United States, 78217 收起 << |
NCT00902746 | - | Completed | - | - | |
NCT00902746 | Dysmenorrhea | Phase 3 | Completed | - | - |
NCT00000897 | HIV Infections | Not Applicable | Completed | - | United States, California ... 展开 >> San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, Florida Univ of Florida Health Science Ctr / Pediatrics Jacksonville, Florida, United States, 32209 United States, New York Children's Hosp at Albany Med Ctr Albany, New York, United States, 12208 SUNY / Erie County Med Ctr at Buffalo Buffalo, New York, United States, 14215 United States, North Carolina Univ of North Carolina Chapel Hill, North Carolina, United States, 275997215 United States, Washington Univ of Washington Seattle, Washington, United States, 98104 收起 << |
NCT00821496 | Healthy | Phase 1 | Completed | - | United States, Arizona ... 展开 >> MDS Pharma Services Phoenix, Arizona, United States, 85283 收起 << |
NCT00453960 | Endometrial Hyperplasia | Phase 2 | Completed | - | Italy ... 展开 >> Menopause Centre, Department of Gynecology and Obstetrics, Policlinico Universitario "G.Martino" Messina, Italy, 98100 收起 << |
NCT00999479 | Endometrioma | Not Applicable | Withdrawn(Poor enrollment) | - | United States, Oklahoma ... 展开 >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT00184795 | Menopause Men... 展开 >>opausal Vasomotor Symptoms 收起 << | Phase 3 | Completed | - | - |
NCT00350480 | Uterine Hemorrhage ... 展开 >> Menorrhagia 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Kaiser Permanente Sunset Los Angeles, California, United States, 90027 收起 << |
NCT00522873 | Postmenopause | Phase 3 | Completed | - | - |
NCT00522873 | - | Completed | - | - | |
NCT00600106 | Myocardial Ischemia | Not Applicable | Completed | - | United States, California ... 展开 >> Cedars-Sinai Women's Heart Center, 8631 W. 3rd St, Suite 740 Los Angeles, California, United States, 90048 收起 << |
NCT03353857 | Biological Availability | Phase 1 | Active, not recruiting | December 18, 2018 | Germany ... 展开 >> CRS Clinical-Research-Services Mannheim GmbH Mannheim, Baden-Württemberg, Germany, 68167 CRS Clinical-Research-Services Mönchengladbach GmbH Mönchengladbach, Nordrhein-Westfalen, Germany, 41061 收起 << |
NCT00732693 | Premature Ovarian Failure | Phase 4 | Completed | - | United Kingdom ... 展开 >> Royal Infirmary of Edinburgh Edinburgh, United Kingdom, EH16 4SA Royal Hospital for Sick Children Edinburgh, United Kingdom, EH9 1LF 收起 << |
NCT01036893 | Healthy Volunteers | Phase 1 | Completed | - | Germany ... 展开 >> FOCUS GmbH Neuss, Germany, D-41460 收起 << |
NCT00746096 | Dysmenorrhea | Phase 3 | Completed | - | - |
NCT00746096 | - | Completed | - | - | |
NCT02036879 | Cystic Fibrosis (CF) | Not Applicable | Recruiting | December 2018 | United States, Texas ... 展开 >> Children's Medical Center Recruiting Dallas, Texas, United States, 75207 Contact: Ashley Keller, MPH 214-648-2817 ashley.keller@utsouthwestern.edu Principal Investigator: Raksha Jain, MD, MSCI UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Ashley Keller, MPH 214-648-2817 ashley.keller@utsouthwestern.edu Principal Investigator: Raksha Jain, MD, MSCI Sub-Investigator: David Finklea, MD 收起 << |
NCT01160315 | Fertility Preservation ... 展开 >> Alkylating Agents Lymphoma 收起 << | Phase 2 Phase 3 | Completed | - | Belgium ... 展开 >> Algemeen Ziekenhuis Stuivenberg Antwerpen, Belgium, 2060 AZ St Jan Brugges, Belgium, 8000 Bordet Brussels, Belgium, 1000 Erasme Hospital Brussels, Belgium, 1070 AZ-VUB Brussels, Belgium, 1090 St Luc University Brussels, Belgium, 1200 CHRU Lille Lille, Belgium, 59037 France CHU Dijon Dijon, France, 21034 CHU Nancy Nancy, France, 54511 Henry-Mondor Hospital Paris-Creteil, France, 94010 Hôpital Hotel Dieu Paris, France, 75004 St Louis Hospital Paris, France, 75475 CHU St Antoine Paris, France, 75571 Centre Henri Beckerel Rouen, France, 76038 Italy Instituto Europeo di oncologia Milano, Italy, 1-20141 收起 << |
NCT02738502 | Maternal-fetal Infection Trans... 展开 >>mission 收起 << | Phase 2 | Recruiting | February 2020 | France ... 展开 >> Hôpital Antoine Béclère Recruiting Clamart, France, 92140 Principal Investigator: Véronique Chambrin, MD Hôpital Louis Mourier Recruiting Colombes, France, 92700 Sub-Investigator: Laurent Mandelbrot, MD Principal Investigator: Françoise Meier, MD Hôpital Sud Francilien Recruiting Corbeil-essonnes, France, 91106 Principal Investigator: Amélie Chabrol, MD Hôpital Bicêtre Recruiting Le Kremlin Bicêtre, France, 94275 Principal Investigator: Delphine Peretti, MD Hôpital la Pitié Salpétrière Recruiting Paris, France, 75013 Principal Investigator: Roland Tubiana, MD 收起 << |
NCT01631981 | Endometriosis | Phase 2 | Completed | - | Hungary ... 展开 >> Synexus Magyarország Kft. Budapest, Hungary, 1036 Semmelweis Egyetem II. Szülészeti és Nőgyógyászati Klinika Budapest, Hungary, 1082 Debreceni Egyetem Orvos-es Egeszsegtudomanyi Centrum Szuleszeti es Nogyogyaszati Klinika Debrecen, Hungary, 4012 Pécsi Tudományegyetem Klinikai Központ Szülészeti és Nőgyógyászati Klinika Pecs, Hungary, 7624 Szegedi Tudományegyetem Szent-Györgyi Albert Klinkai Központ Szülészeti és Nőgyógyászati Klinika Szeged, Hungary, 6725 Poland Medica Pro Familia Sp. z o.o. S.K.A. - Oddział Katowie Katowice, Poland, 40-954 Specjalistyczny Gabinet Ginekologiczno-Położniczy Lublin, Poland, 20-496 Klinika Endokrynologii I Nieplodnosci Rozrodu, Ginekologiczno Polozniczy Szpital UM Poznan, Poland, 60-535 Lubelskie Centrum Diagnostyczne Swidnik, Poland, 21040 VitroLive Sp. Z o.o Szczecin, Poland, 71-074 NZOZ Lecznica Medea Warszawa, Poland, 01-826 Private practice Warszawa, Poland, 02-201 Centralny Szpital Kliniczny MSWiA, Klinika Połoznictwa, Chorob Kobiecych i Ginekologii Onkologicznej Warszawa, Poland, 02-507 Medeor Plus Szpital Wielospecjalistyczny Łódź, Poland, 91-308 Klinka Ginekologii Operacyjnej, Instytut-Centrum Zdrowia Matki Polki Łódź, Poland, 93-338 Romania Euromedica Hospital SA Baia Mare, Romania, 430032 Centrul Medical de Diagnostic si Tratament Ambulator Neomed SRL Brasov, Romania, 500283 Genesys Fertility Center SRL Bucharest, Romania, 011475 Centrul Medical Euromed SRL Bucharest, Romania, 020762 Spitalul Clinic "Nicolae Malaxa" Bucharest, Romania, 022441 收起 << |
NCT02969590 | Fertility Con... 展开 >>traception 收起 << | Phase 4 | Completed | - | United States, Oregon ... 展开 >> Oregon Health & Science University Portland, Oregon, United States, 97239 收起 << |
NCT00600106 | - | Completed | - | - | |
NCT01705249 | Menopause Hea... 展开 >>lthy 收起 << | Phase 4 | Completed | - | Norway ... 展开 >> Novo Nordisk Investigational Site Kristiansand, Norway Novo Nordisk Investigational Site Kristiansund, Norway Novo Nordisk Investigational Site Larvik, Norway Novo Nordisk Investigational Site Oslo, Norway, 0309 Novo Nordisk Investigational Site Trondheim, Norway, NO-7012 Sweden Novo Nordisk Investigational Site Borås, Sweden, 503 32 Novo Nordisk Investigational Site Göteborg, Sweden, 411 19 Novo Nordisk Investigational Site Göteborg, Sweden, 418 33 Novo Nordisk Investigational Site Kungsbacka, Sweden, 434 30 Novo Nordisk Investigational Site Linköping, Sweden, 581 85 Novo Nordisk Investigational Site Linköping, Sweden, 582 20 Novo Nordisk Investigational Site Linköping, Sweden, 582 22 Novo Nordisk Investigational Site Norrköping, Sweden, 602 22 Novo Nordisk Investigational Site Norrköping, Sweden, 602 32 Novo Nordisk Investigational Site Sigtuna, Sweden, 193 30 Novo Nordisk Investigational Site Stockholm, Sweden, 111 37 Novo Nordisk Investigational Site Stockholm, Sweden, 111 57 Novo Nordisk Investigational Site Södertälje, Sweden, 151 23 Novo Nordisk Investigational Site Uddevalla, Sweden, 451 30 收起 << |
NCT00229996 | Endometriosis ... 展开 >> Pelvic Pain 收起 << | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Womens Hospital Boston, Massachusetts, United States, 02215 收起 << |
NCT00212342 | Dysmenorrhea | Phase 3 | Completed | - | - |
NCT02693002 | Menopause | Phase 4 | Terminated(Enrollment goals no... 展开 >>t being met) 收起 << | - | United States, Kentucky ... 展开 >> University of Kentucky Lexington, Kentucky, United States, 40536 收起 << |
NCT03343067 | Endometriosis | Phase 3 | Terminated(Strategic considera... 展开 >>tions) 收起 << | - | - |
NCT01477632 | Menopause Hea... 展开 >>lthy 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Neu-Ulm, Germany, 89231 收起 << |
NCT00413764 | Sexual Dysfunction | Phase 3 | Completed | - | - |
NCT01209143 | - | Completed | - | - | |
NCT00212277 | Dysmenorrhea | Phase 3 | Completed | - | - |
NCT00338052 | Contraception | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Warner Chilcott Investigational Site Phoenix, Arizona, United States, 85031 Warner Chilcott Investigational Site Phoenix, Arizona, United States, 85050 Warner Chilcott Investigational Site Tempe, Arizona, United States, 85283 United States, California Warner Chilcott Investigational Site Carmichael, California, United States, 95608 United States, Florida Warner Chilcott Investigational Site Boynton Beach, Florida, United States, 33437 Warner Chilcott Investigational Site Leesburg, Florida, United States, 34748 Warner Chilcott Investigational Site Miami, Florida, United States, 33143 Warner Chilcott Investigational Site Miami, Florida, United States, 33186 Warner Chilcott Investigational Site West Palm Beach, Florida, United States, 33401 United States, Georgia Warner Chilcott Investigational Site Decatur, Georgia, United States, 30034 Warner Chilcott Investigational Site Roswell, Georgia, United States, 30075 United States, Illinois Warner Chilcott Investigational Site Peoria, Illinois, United States, 61615 United States, Kentucky Warner Chilcott Investigational Site Lexington, Kentucky, United States, 40509 Warner Chilcott Investigational Site Louisville, Kentucky, United States, 40291 United States, North Carolina Warner Chilcott Investigational Site New Bern, North Carolina, United States, 28562 Warner Chilcott Investigational Site Winston Salem, North Carolina, United States, 27103 United States, Pennsylvania Warner Chilcott Investigational Site Philadelphia, Pennsylvania, United States, 19114 United States, South Carolina Warner Chilcott Investigational Site Greenville, South Carolina, United States, 29607 United States, Utah Warner Chilcott Investigational Site Pleasant Grove, Utah, United States, 84062 Warner Chilcott Investigational Site Salt Lake City, Utah, United States, 84017 Warner Chilcott Investigational Site Sandy, Utah, United States, 84070 United States, Virginia Warner Chilcott Investigational Site Virginia Beach, Virginia, United States, 23456 United States, Washington Warner Chilcott Investigational Site Seattle, Washington, United States, 98105 收起 << |
NCT02925494 | Uterine Fibroids ... 展开 >> Heavy Menstrual Bleeding 收起 << | Phase 3 | Active, not recruiting | April 8, 2019 | - |
NCT02693002 | - | Terminated(Enrollment goals no... 展开 >>t being met) 收起 << | - | - | |
NCT03213457 | Endometriosis | Phase 3 | Recruiting | December 31, 2020 | - |
NCT01209143 | Solid Cancers | Phase 1 | Completed | - | United States, California ... 展开 >> Stanford, California, United States, 94305 United States, Michigan Detroit, Michigan, United States, 48201 United States, Texas Houston, Texas, United States, 77030 收起 << |
NCT02210702 | Postpartum Depressive Mood ... 展开 >> Postpartum Sexual Function 收起 << | Phase 4 | Unknown | - | United States, Virginia ... 展开 >> Sentara Norfolk General Hospital Recruiting Norfolk, Virginia, United States, 23507 收起 << |
NCT01253824 | Healthy | Phase 3 | Completed | - | - |
NCT02705963 | Solid Tumors | Phase 1 | Recruiting | May 21, 2019 | United States, Michigan ... 展开 >> Karmanos Cancer Institute Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact 313-576-8730 Principal Investigator: Amy M Weise Henry Ford Hospital Henry Ford Recruiting Detroit, Michigan, United States, 48202 2689 Contact 313-916-8862 Principal Investigator: Ding Wang United States, Oklahoma University of Oklahoma Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact 405-271-4022 Principal Investigator: Kathleen Moore Belgium Novartis Investigative Site Recruiting Edegem, Belgium, 2650 Novartis Investigative Site Recruiting Namur, Belgium, 5000 Novartis Investigative Site Recruiting Wilrijk, Belgium, 2610 Netherlands Novartis Investigative Site Recruiting Maastricht, Netherlands, 6202AZ Spain Novartis Investigative Site Recruiting Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Recruiting Madrid, Spain, 28034 Novartis Investigative Site Recruiting Malaga, Spain, 29010 United Kingdom Novartis Investigative Site Recruiting London, United Kingdom, W1G 6AD 收起 << |
NCT01077505 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT02170038 | Pharmacokinetics | Phase 1 | Completed | - | Germany ... 展开 >> Berlin, Germany, 13353 收起 << |
NCT00391807 | Contraception | Phase 3 | Completed | - | - |
NCT01076621 | - | Completed | - | Norway ... 展开 >> Rud, Norway, 1309 Sweden Göteborg, Sweden, 416 85 收起 << | |
NCT03204331 | Endometriosis Related Pain | Phase 3 | Recruiting | June 30, 2020 | - |
NCT00391807 | - | Completed | - | - | |
NCT03204318 | Endometriosis Related Pain | Phase 3 | Recruiting | June 30, 2020 | - |
NCT01596010 | Menopause Hea... 展开 >>lthy 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Neu-Ulm, Germany, 89231 收起 << |
NCT02542410 | Endometriosis | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT01953809 | Infections, Bacterial | Phase 1 | Withdrawn(Emerging GSK1322322 ... 展开 >>pre-clinical data ID'd potentially reactive metabolites previously not seen that changed the risk benefit profile and led to a termination) 收起 << | March 2015 | - |
NCT00477633 | Contraception | Phase 3 | Completed | - | - |
NCT01040845 | Pharmacokinetics | Phase 1 | Completed | - | United States, North Dakota ... 展开 >> PRACS Institute, Ltd. - Cetero Research Fargo, North Dakota, United States, 58104 收起 << |
NCT01253824 | - | Completed | - | - | |
NCT01246791 | - | Completed | - | - | |
NCT00477633 | - | Completed | - | - | |
NCT02292732 | Cancer | Phase 1 | Withdrawn | May 2017 | - |
NCT01040845 | - | Completed | - | - | |
NCT02480881 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33143 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT03103087 | Heavy Menstrual Bleeding ... 展开 >> Uterine Fibroid 收起 << | Phase 3 | Active, not recruiting | February 28, 2020 | - |
NCT02832180 | Arthritis | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami Research Associates Miami, Florida, United States, 33143 United States, Indiana Covance Evansville Clinical Research Unit Evansville, Indiana, United States, 47710 收起 << |
NCT03049735 | Heavy Menstrual Bleeding ... 展开 >> Uterine Fibroid 收起 << | Phase 3 | Active, not recruiting | December 30, 2019 | - |
NCT01499602 | Endometrial Hyperplasia | Not Applicable | Completed | - | Egypt ... 展开 >> Mansoura University Hospitals,OB/GYN department Mansoura, Dakahlia Governorate, Egypt, 35511 收起 << |
NCT02182791 | HIV Infections | Phase 1 | Completed | - | - |
NCT01246791 | Healthy | Phase 3 | Completed | - | - |
NCT03262727 | Systemic Lupus Erythematosus ... 展开 >> Arthritic Psoriasis Psoriasis Inflammatory Bowel Diseases 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami Research Associates Miami, Florida, United States, 33173-5426 收起 << |
NCT03262740 | Rheumatoid Arthritis | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami Research Associates Miami, Florida, United States, 33173-5426 United States, Utah PRA Health Sciences Salt Lake City, Utah, United States, 84107 收起 << |
NCT00580424 | Women's Health ... 展开 >> Blood Coagulation Disorders 收起 << | Not Applicable | Terminated | July 2009 | United States, Vermont ... 展开 >> University of Vermont Burlington, Vermont, United States, 05405 收起 << |
NCT01266759 | Menorrhagia | Not Applicable | Completed | - | Egypt ... 展开 >> Mansoura University Hospitals,OB/GYN department Mansoura, Dakahlia Governorate, Egypt 收起 << |
NCT00932321 | - | Completed | - | - | |
NCT03106454 | Contraception ... 展开 >> Ovulation 收起 << | Phase 3 | Active, not recruiting | December 2017 | United States, California ... 展开 >> University of Southern California Los Angeles, California, United States, 90033 收起 << |
NCT01486004 | Hepatitis C Virus | Phase 1 | Completed | - | Belgium ... 展开 >> Merksem, Belgium 收起 << |
NCT00932321 | Prevention of Pregnancy | Phase 3 | Completed | - | - |
NCT02245438 | Healthy | Phase 1 | Terminated | - | - |
NCT00474851 | Endometriosis | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT00474851 | - | Completed | - | - | |
NCT00739622 | HIV AIDS ... 展开 >> Oral Contraceptive 收起 << | Phase 1 | Completed | - | - |
NCT02905890 | Bacterial Vaginosis ... 展开 >> HIV 收起 << | Phase 4 | Recruiting | April 2018 | Uganda ... 展开 >> MRC/UVRI Mengo Clinic and Research Station Recruiting Kampala, Uganda Contact: Janet Seeley, PhD Janet.Seeley@lshtm.ac.uk Contact: Yunia Mayanja, MD Yunia.Mayanja@mrcuganda.org 收起 << |
NCT03751124 | Uterine Leiomyoma ... 展开 >> Uterine Fibroids 收起 << | Phase 3 | Enrolling by invitation | March 31, 2021 | United States, Florida ... 展开 >> United States, Florida West Palm Beach, Florida, United States, 33409 收起 << |
NCT03654274 | Endometriosis | Phase 3 | Enrolling by invitation | March 31, 2021 | United States, Arizona ... 展开 >> Tuscon Tucson, Arizona, United States, 85712 United States, Tennessee Chattanooga Chattanooga, Tennessee, United States, 37404 收起 << |
NCT02103569 | Hepatitis C | Phase 1 | Completed | - | - |
NCT02654054 | Uterine Fibroids ... 展开 >> Heavy Menstrual Bleeding 收起 << | Phase 3 | Active, not recruiting | December 19, 2018 | - |
NCT01140217 | Contraceptive Usage | Phase 3 | Completed | - | - |
NCT01344369 | Healthy | Phase 1 | Completed | - | United States, Texas ... 展开 >> Novum Pharmaceutical Research Services Houston, Texas, United States, 77042-4712 收起 << |
NCT03271489 | Heavy Menstrual Bleeding ... 展开 >> Uterine Fibroids 收起 << | Phase 3 | Recruiting | May 16, 2022 | - |
NCT01344369 | - | Completed | - | - | |
NCT01157182 | Healthy | Phase 1 | Completed | - | Canada, Ontario ... 展开 >> Biovail Clinical Research Toronto, Ontario, Canada, M1L 4S4 收起 << |
NCT01157182 | - | Completed | - | - | |
NCT02691494 | Uterine Fibroids ... 展开 >> Heavy Menstrual Bleeding 收起 << | Phase 3 | Active, not recruiting | January 16, 2019 | - |
NCT01181726 | Healthy | Phase 1 | Completed | - | Canada, Ontario ... 展开 >> Biovail Contract Research Toronto, Ontario, Canada, M1L 4S4 收起 << |
NCT01340625 | - | Completed | - | - | |
NCT00458458 | Endometriosis ... 展开 >> Dysmenorrhea Dyspareunia 收起 << | Phase 3 | Unknown | - | United States, New York ... 展开 >> SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 收起 << |
NCT03412890 | Heavy Menstrual Bleeding ... 展开 >> Uterine Fibroid 收起 << | Phase 3 | Enrolling by invitation | July 30, 2020 | United States, Arizona ... 展开 >> Mesa Mesa, Arizona, United States, 85209 United States, Colorado Denver Denver, Colorado, United States, 80209 United States, Florida Margate Margate, Florida, United States, 33063 United States, Louisiana Metairie Metairie, Louisiana, United States, 70001 United States, Nevada Las Vegas Las Vegas, Nevada, United States, 89128 United States, Ohio Englewood Englewood, Ohio, United States, 45322 United States, Texas Houston Houston, Texas, United States, 77054 收起 << |
NCT01597986 | Pharmacokinetics of Isavuconaz... 展开 >>ole Pharmacokinetics of Ethinyl Estradiol and Norethindrone Healthy Volunteers 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami Miami, Florida, United States, 33014 收起 << |
NCT01391052 | Heavy Menstrual Bleeding ... 展开 >> Menorrhagia Hypermenorrhea 收起 << | Phase 4 | Unknown | January 2013 | United States, Texas ... 展开 >> Scott and White Hospital and Clinic Recruiting Temple, Texas, United States, 76508 Contact: Wendy M White, CCRP 254-724-8301 wewhite@swmail.sw.org Principal Investigator: Patricia J Sulak, MD 收起 << |
NCT01667978 | Pregnancy HIV... 展开 >> AIDS 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Los Angeles County Hospital University of Southern California (LAC USC) Los Angeles, California, United States, 90033-1029 Los Angeles County University of Southern California Los Angeles, California, United States, 90033-1029 收起 << |
NCT02652650 | Healthy | Phase 1 | Completed | - | Belgium ... 展开 >> Merksem, Belgium 收起 << |
NCT01181726 | - | Completed | - | - | |
NCT02353247 | Etonogestrel Contraceptive Imp... 展开 >>lant, Bothersome Bleeding 收起 << | Not Applicable | Active, not recruiting | November 2018 | United States, Kentucky ... 展开 >> Kosair Children's Hospital Louisville, Kentucky, United States, 40202 收起 << |
NCT03594604 | Menstrual Flow Altered | Phase 4 | Completed | - | - |
NCT01340625 | Bioequivalence | Phase 1 | Completed | - | United States, North Dakota ... 展开 >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 收起 << |
NCT01667978 | - | Completed | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!